Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Lenacapavir (GS-6207) in Combination With Other Antiretroviral Agents in People Living With HIV [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating lenacapavir (GS-6207) in combination with other antiretroviral agents for people living with HIV has completed and results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lenacapavir (lenacapavir)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Phase 2 | Status: COMPLETED | Results posted: 2022-12-19